価格表

在庫・価格 : 2024年05月22日 13時38分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Human Pluripotent Stem Cell Functional Identification Kit
データシート※最新のデータシートでない場合があります
SC027B RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥157,000
(未発注)
追加

在庫・価格 : 2024年05月22日 13時38分 現在

Human Pluripotent Stem Cell Functional Identification Kit

  • 商品コード:SC027B
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥157,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Furusawa T et al. Characteristics of bovine inner cell mass-derived cell lines and their fate in chimeric conceptuses. Biol. Reprod. 2013 Aug;89(2):28
Furusawa T et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
2 Kim Y et al. The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation. Stem Cells Int 2016;2016:1329459
Kim Y et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Shinozawa T et al. Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes. Stem Cell Reports 2017 Feb;8(2):226-234
Shinozawa T et al
2017/01/01
Sample Type: Whole Cells PubMed
4 Nam Y et al. Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration. Stem Cell Res Ther 2017 Jan;8(1):16
Nam Y et al
2017/01/01
Sample Type: Whole Cells PubMed
5 Szablowska-Gadomska I et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. Acta Neurobiol Exp (Wars) 2012;72(4):337-50
Szablowska-Gadomska I et al
2012/01/01
Species: Human, Applications: ICC PubMed
6 Krueger WH et al. Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular health. PLoS ONE 2013;8(7):e67296
Krueger WH et al
2013/01/01
Species: Human, Applications: Bioassay PubMed
7 Maguire JA et al. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res 2019 01;34:101361
Maguire JA et al
2019/01/01
PubMed
8 Chen B et al. Inducible overexpression of RUNX1b/c in human embryonic stem cells blocks early hematopoiesis from mesoderm. J Mol Cell Biol 2017 08;9(4):262-273
Chen B et al
2017/01/01
PubMed
9 Gagne AL et al. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res 2018 Aug;31:157-160
Gagne AL et al
2018/01/01
PubMed
10 Deshpande A et al. Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder. Cell Rep 2017 Dec;21(10):2678-2687
Deshpande A et al
2017/01/01
PubMed
11 Nakashima Y et al. Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells. Mol. Ther. 2018 Jul;26(7):1715-1734
Nakashima Y et al
2018/01/01
PubMed
12 Altomare C et al. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade. Europace 2016 Dec;18(suppl 4):iv67-iv76
Altomare C et al
2016/01/01
PubMed
13 Dzamko N et al. Toll-like receptor 2 is increased in neurons in Parkinsons disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 2016 Nov;
Dzamko N et al
2016/01/01
PubMed
14 Kanton S et al. Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature 2019 10;574(7778):418-422
Kanton S et al
2019/01/01
PubMed
15 Larsen SB et al. Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson"s disease carrying the p.D620N mutation in VPS35. Stem Cell Res 2020 05;45:101776
Larsen SB et al
2020/01/01
PubMed
16 Duarte AJ et al. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene. Stem Cell Res 2019 12;41:101595
Duarte AJ et al
2019/01/01
PubMed
17 Duarte AJ et al. Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation. Stem Cell Res 2020 05;45:101794
Duarte AJ et al
2020/01/01
PubMed
18 Park S et al. Establishment of PITX3-mCherry knock-in reporter human embryonic stem cell line (WAe009-A-23). Stem Cell Res 2019 08;39:101499
Park S et al
2019/01/01
PubMed
19 Lu C et al. Generation of a knock-in MAP2-tdTomato reporter human embryonic stem cell line with inducible expression of NEUROG2/1 (NYGCe001-A). Stem Cell Res 2019 12;41:101643
Lu C et al
2019/01/01
PubMed
20 Pagliari S et al. YAP-TEAD1 control of cytoskeleton dynamics and intracellular tension guides human pluripotent stem cell mesoderm specification. Cell Death Differ 2021 04;28(4):1193-1207
Pagliari S et al
2021/01/01
Species: Human PubMed
21 Zhang Y et al. The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin. Nat Cell Biol 2020 11;22(11):1332-1345
Zhang Y et al
2020/01/01
Species: Human PubMed
22 Jahng JWS et al. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Res 2021 05;53:102284
Jahng JWS et al
2021/01/01
Species: Human PubMed
23 Barbuti PA et al. Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson"s disease patient carrying the heterozygous p.A30P mutation in SNCA. Stem Cell Res 2020 10;48:101951
Barbuti PA et al
2020/01/01
Species: Human, Applications: Bioassay PubMed
24 Iannello G et al. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res 2021 07;54:102432
Iannello G et al
2021/01/01
Species: SC027, Applications: Bioassay PubMed
25 Figiel-Dabrowska A et al. Neurogenic and Neuroprotective Potential of Stem/Stromal Cells Derived from Adipose Tissue. Cells 2021 06;10(6)
Figiel-Dabrowska A et al
2021/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Furusawa T et al. Characteristics of bovine inner cell mass-derived cell lines and their fate in chimeric conceptuses. Biol. Reprod. 2013 Aug;89(2):28
    Furusawa T et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kim Y et al. The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation. Stem Cells Int 2016;2016:1329459
    Kim Y et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Shinozawa T et al. Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes. Stem Cell Reports 2017 Feb;8(2):226-234
    Shinozawa T et al
    2017/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Nam Y et al. Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration. Stem Cell Res Ther 2017 Jan;8(1):16
    Nam Y et al
    2017/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Szablowska-Gadomska I et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. Acta Neurobiol Exp (Wars) 2012;72(4):337-50
    Szablowska-Gadomska I et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Krueger WH et al. Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular health. PLoS ONE 2013;8(7):e67296
    Krueger WH et al
    2013/01/01
  • 備考:
    Species: Human, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Maguire JA et al. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res 2019 01;34:101361
    Maguire JA et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chen B et al. Inducible overexpression of RUNX1b/c in human embryonic stem cells blocks early hematopoiesis from mesoderm. J Mol Cell Biol 2017 08;9(4):262-273
    Chen B et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Gagne AL et al. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res 2018 Aug;31:157-160
    Gagne AL et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Deshpande A et al. Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder. Cell Rep 2017 Dec;21(10):2678-2687
    Deshpande A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Nakashima Y et al. Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells. Mol. Ther. 2018 Jul;26(7):1715-1734
    Nakashima Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Altomare C et al. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade. Europace 2016 Dec;18(suppl 4):iv67-iv76
    Altomare C et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Dzamko N et al. Toll-like receptor 2 is increased in neurons in Parkinsons disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 2016 Nov;
    Dzamko N et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Kanton S et al. Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature 2019 10;574(7778):418-422
    Kanton S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Larsen SB et al. Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson"s disease carrying the p.D620N mutation in VPS35. Stem Cell Res 2020 05;45:101776
    Larsen SB et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Duarte AJ et al. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene. Stem Cell Res 2019 12;41:101595
    Duarte AJ et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Duarte AJ et al. Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation. Stem Cell Res 2020 05;45:101794
    Duarte AJ et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Park S et al. Establishment of PITX3-mCherry knock-in reporter human embryonic stem cell line (WAe009-A-23). Stem Cell Res 2019 08;39:101499
    Park S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lu C et al. Generation of a knock-in MAP2-tdTomato reporter human embryonic stem cell line with inducible expression of NEUROG2/1 (NYGCe001-A). Stem Cell Res 2019 12;41:101643
    Lu C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Pagliari S et al. YAP-TEAD1 control of cytoskeleton dynamics and intracellular tension guides human pluripotent stem cell mesoderm specification. Cell Death Differ 2021 04;28(4):1193-1207
    Pagliari S et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Zhang Y et al. The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin. Nat Cell Biol 2020 11;22(11):1332-1345
    Zhang Y et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Jahng JWS et al. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Res 2021 05;53:102284
    Jahng JWS et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Barbuti PA et al. Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson"s disease patient carrying the heterozygous p.A30P mutation in SNCA. Stem Cell Res 2020 10;48:101951
    Barbuti PA et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Iannello G et al. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res 2021 07;54:102432
    Iannello G et al
    2021/01/01
  • 備考:
    Species: SC027, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Figiel-Dabrowska A et al. Neurogenic and Neuroprotective Potential of Stem/Stromal Cells Derived from Adipose Tissue. Cells 2021 06;10(6)
    Figiel-Dabrowska A et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed